Literature DB >> 25180504

Real-world impact of comparative effectiveness research findings on clinical practice.

Teresa B Gibson1, Emily D Ehrlich, Jennifer Graff, Robert Dubois, Amanda M Farr, Michael Chernew, A Mark Fendrick.   

Abstract

OBJECTIVES: Unprecedented funding for comparative effectiveness research (CER) to help provide better evidence for decision making as a way to lower costs and improve quality is under way. Yet how research findings are adopted and applied will impact the nation's return on this investment. We examine the relationship between the publication of findings from 4 seminal CER trials, the release of subsequent clinical practice guidelines (CPGs), and utilization trends for associated surgical interventions, diagnostic interventions, or medications. STUDY
DESIGN: Retrospective, observational study.
METHODS: Using a large national administrative claims database, we examined time series utilization trends before and after publication of findings from 4 CER trials published within the last decade.
RESULTS: We found no clear pattern of utilization in the first 4 quarters after publication. However, we found that results for 2 of the studies were in concert with the release of CPGs and publication of study results. The trend in intensive statin therapy rose rapidly starting at the end of 2007, while the trend in standard therapy remained relatively constant (PROVE-IT). And, 9 months after trial publication, breast magnetic resolution imaging (MRI) utilization rates rose 43.2%, from 0.033 to 0.048 per 100 enrollees (Mammography With MRI).
CONCLUSIONS: Our analysis of 4 case studies supports the call others have made to translate and disseminate CER findings to improve application of research findings to clinical practice and the need for continued development and dissemination of CPGs that serve to synthesize research findings and guide practitioners in clinical decision making. Further research is needed to determine whether these findings apply to different medical topics.

Mesh:

Substances:

Year:  2014        PMID: 25180504

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  3 in total

1.  comparative effectiveness research collaboration and precision medicine.

Authors:  Price A; Chatterjee P; Biswas R
Journal:  Ann Neurosci       Date:  2015-07

Review 2.  Comparative effectiveness research and its utility in In-clinic practice.

Authors:  Amit Dang; Kirandeep Kaur
Journal:  Perspect Clin Res       Date:  2016 Jan-Mar

3.  Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.

Authors:  Shelagh M Szabo; Ishan Hirji; Karissa M Johnston; Ariadna Juarez-Garcia; Joseph M Connors
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.